| 0.966 | 0.001 | 0.966 | Gastric antisecretory | | |
| 0.957 | 0.001 | 0.957 | Potassium channel (ATP-sensitive) blocker | | |
| 0.939 | 0.001 | 0.939 | H+/K+-transporting ATPase inhibitor | | |
| 0.869 | 0.001 | 0.869 | Antibacterial (Helicobacter pylori) | | |
| 0.714 | 0.004 | 0.714 | Potassium channel blocker | | |
| 0.499 | 0.003 | 0.499 | ABCA1 expression enhancer | | |
| 0.447 | 0.012 | 0.447 | Calcium channel activator | | |
| 0.436 | 0.002 | 0.436 | Potassium channel (Inward rectifier) blocker | | |
| 0.422 | 0.006 | 0.422 | Phosphodiesterase inhibitor | | |
| 0.343 | 0.005 | 0.343 | Phosphodiesterase 4D inhibitor | | |
| 0.326 | 0.004 | 0.326 | Phosphodiesterase 4A inhibitor | | |
| 0.372 | 0.072 | 0.372 | Toll-Like receptor agonist | | |
| 0.37 | 0.073 | 0.37 | Toll-Like receptor 7 agonist | | |
| 0.291 | 0.039 | 0.291 | Gastrin inhibitor | | |
| 0.283 | 0.06 | 0.283 | Tumour necrosis factor alpha release inhibitor | | |
| 0.24 | 0.034 | 0.24 | Tumour necrosis factor antagonist | | |
| 0.194 | 0.025 | 0.194 | MAP kinase 12 inhibitor | | |
| 0.193 | 0.036 | 0.193 | Interleukin 1 antagonist | | |
| 0.179 | 0.025 | 0.179 | Interleukin 1b antagonist | | |
| 0.176 | 0.063 | 0.176 | ATPase inhibitor | | |
| 0.143 | 0.039 | 0.143 | MAP kinase 13 inhibitor | | |
| 0.181 | 0.079 | 0.181 | P-glycoprotein inhibitor | | |
| 0.262 | 0.166 | 0.262 | Antibacterial | | |
| 0.101 | 0.015 | 0.101 | NMDA 2B receptor antagonist | | |
| 0.148 | 0.064 | 0.148 | Toll-Like receptor 9 antagonist | | |
| 0.092 | 0.013 | 0.092 | Fatty acid synthase inhibitor | | |
| 0.198 | 0.121 | 0.198 | Spasmolytic | | |
| 0.132 | 0.075 | 0.132 | Bone formation stimulant | | |
| 0.091 | 0.04 | 0.091 | Na+ K+ transporting ATPase inhibitor | | |
| 0.084 | 0.036 | 0.084 | Phosphodiesterase VI inhibitor | | |
| 0.077 | 0.03 | 0.077 | Janus tyrosine kinase 1 inhibitor | | |
| 0.222 | 0.178 | 0.222 | Histamine release inhibitor | | |
| 0.067 | 0.029 | 0.067 | Phosphodiesterase 4C inhibitor | | |
| 0.088 | 0.05 | 0.088 | Histamine H2 receptor antagonist | | |
| 0.022 | 0.005 | 0.022 | Prokineticin receptor 1 antagonist | | |
| 0.087 | 0.071 | 0.087 | Platelet activating factor alpha antagonist | | |
| 0.078 | 0.063 | 0.078 | Phosphodiesterase IV inhibitor | | |
| 0.052 | 0.051 | 0.052 | Acetyl-CoA transferase 2 inhibitor | | |